Stephen Christopher Linthwaite

Executive

Chairman & CEO

US·SEC (Form 4)

Fluidigm Corp

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 24 Feb 2022 for Fluidigm CORP. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Stephen Christopher Linthwaite: trading record in brief

Stephen Christopher Linthwaite is a declared insider of Standard Biotools Inc. (chief executive), with filings sourced from SEC (Form 4). Between 20 May 2021 and 22 February 2022, the trades on record add up to 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 24 February 2022, reports an option exercise in Standard Biotools Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.